Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic

Study Overview
=================
Brief Summary
-----------------
Ophthalmologic damages secondary to COVID-19 coronavirus infection are little described. The ocular involvement is probably multiple, ranging from pathologies of the anterior segment such as conjunctivitis and anterior uveitis to disorders that threaten vision such as retinitis or optic neuropathy. On the other hand, in addition to this impairment, when patients are hospitalized for acute respiratory failure, complications related to possible resuscitation, medication prescriptions, positioning and oxygenation. COVID-19 itself, has several components: An apoptotic action of the viral attack which will generate cellular destruction, whether pulmonary, cardiac or renal or maybe ocular A secondary autoimmune action with the development of major vascular inflammation, possibly reaching the retinal, choroidal, and optic nerve vessels. A secondary hyper inflammatory syndrome with flashing hypercytokinemia and multi-organ decompensation is described in 3,7% to 4 ,3% of severe cases. A thromboembolic action

Detailed Description
-----------------
Upon discharge from hospital for COVID-19 infection (or during a telephone call for patients already discharged at the start of the study), patients will be informed of the study. An ophthalmology appointment will be given to them between 4 and 6 months after their discharge. During the ophthalmology appointment, the patient's clinical data will be collected during an interview (medical and treatment history, blood group). The patient will benefit from a full ophthalmological examination.

Official Title
-----------------
Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic

Conditions
-----------------
COVID19, Ophthalmopathy

Intervention / Treatment
-----------------
* Procedure: Ophthalmologic exam


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patients having been hospitalized for a confirmed COVID-19 infection (CT-scanner or PCR- Polymerase chain reaction) Exclusion Criteria: Pregnant or breastfeeding woman

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Other
Intervention Model: Single Group Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Ophthalmologic exam<br> | Procedure: Ophthalmologic exam<br>* Visual acuity (ETDRS exam) Slit lamp examination : fluorescein test, Oxford score, break up time, Schirmer II test Lipiview Eye pressure measurement (air tonometer) Wide field retinophotography Multicolor and auto-fluorescence retinophotography Indocyanine green retinal angiography Optical coherence tomography (OCT) B posterior pole scan OCT Angiography (OCT-A) of the optic nerve and posterior pole Adaptive optics Visual field (Humphrey)<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Description of the ophthalmological problems observed | Multimodal ophthalmologic imaging | 6 months after discharge of hospitalization | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
COVID19